(NASDAQ:LEXX) ("Lexaria" or the "Company"), a global innovator in oral drug delivery platforms, announces that dosing has been completed in its 2026 Animal Study #2 (GLP-1-A26-2) evaluating a number of formulation enhancements with 2 next-generation glucagon-like peptide-1 ("GLP-1") drugs (the "Study") to explore the potential for improved DehydraTECH TM performance as well as potentially stake new intellectual property claims
We can get Wegovy approved sometimes for patients with a history of a prior heart attack, explains Lazarus
When combined with regular exercise and a nutritious diet, lipotropic injections can be a helpful tool in your weight loss journey
Normal enzymes do not exclude elevated SAH, low glutathione or impaired metabolic reserve
Storage of cereal and pseudocereal wholemeal flours in paper bags at 20 C and 50% relative humidity for 3 months caused a folate decrease of 45%, 37%, 1938%, 41%, and 23% in wheat, rye, amaranth, buckwheat, and quinoa, resp